Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSIW) Net Income towards Common Stockholders (2022 - 2025)

TriSalus Life Sciences' Net Income towards Common Stockholders history spans 4 years, with the latest figure at -$9.8 million for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders rose 10.45% year-over-year to -$9.8 million; the TTM value through Dec 2025 reached -$71.1 million, down 113.99%, while the annual FY2025 figure was -$69.7 million, 109.7% down from the prior year.
  • Net Income towards Common Stockholders reached -$9.8 million in Q4 2025 per TLSIW's latest filing, up from -$41.3 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $2.3 million in Q1 2022 to a low of -$41.3 million in Q3 2025.
  • Average Net Income towards Common Stockholders over 4 years is -$12.3 million, with a median of -$9.5 million recorded in 2023.
  • Peak YoY movement for Net Income towards Common Stockholders: surged 76.73% in 2023, then crashed 1189.01% in 2025.
  • A 4-year view of Net Income towards Common Stockholders shows it stood at -$25.4 million in 2022, then crashed by 43.62% to -$36.4 million in 2023, then soared by 70.11% to -$10.9 million in 2024, then grew by 10.45% to -$9.8 million in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Net Income towards Common Stockholders are -$9.8 million (Q4 2025), -$41.3 million (Q3 2025), and -$9.0 million (Q2 2025).